International Biotechnology Trust plc
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies fo… Read more
International Biotechnology Trust plc (IBT) - Total Assets
Latest total assets as of August 2025: GBX284.04 Million GBX
Based on the latest financial reports, International Biotechnology Trust plc (IBT) holds total assets worth GBX284.04 Million GBX as of August 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
International Biotechnology Trust plc - Total Assets Trend (2000–2025)
This chart illustrates how International Biotechnology Trust plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
International Biotechnology Trust plc - Asset Composition Analysis
Current Asset Composition (August 2025)
International Biotechnology Trust plc's total assets of GBX284.04 Million consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 5.3% |
| Accounts Receivable | GBX66.00K | 0.0% |
| Inventory | GBX0.00 | 0.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how International Biotechnology Trust plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: International Biotechnology Trust plc's current assets represent 0.0% of total assets in 2025, unchanged from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, up from 0.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is accounts receivable at 0.0% of total assets.
International Biotechnology Trust plc Competitors by Total Assets
Key competitors of International Biotechnology Trust plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
International Biotechnology Trust plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - International Biotechnology Trust plc generates 0.07x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - International Biotechnology Trust plc is currently not profitable relative to its asset base.
International Biotechnology Trust plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.12 | 0.46 | 4.04 |
| Quick Ratio | 0.12 | 0.46 | 4.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX-36.46 Million | GBX -18.56 Million | GBX 9.68 Million |
International Biotechnology Trust plc - Advanced Valuation Insights
This section examines the relationship between International Biotechnology Trust plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.26 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -7.8% |
| Total Assets | GBX284.04 Million |
| Market Capitalization | $997.94 USD |
Valuation Analysis
Below Book Valuation: The market values International Biotechnology Trust plc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: International Biotechnology Trust plc's assets decreased by 7.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for International Biotechnology Trust plc (2000–2025)
The table below shows the annual total assets of International Biotechnology Trust plc from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-08-31 | GBX284.04 Million | -7.83% |
| 2024-08-31 | GBX308.15 Million | +1.08% |
| 2023-08-31 | GBX304.87 Million | -6.74% |
| 2022-08-31 | GBX326.92 Million | -6.01% |
| 2021-08-31 | GBX347.83 Million | +14.91% |
| 2020-08-31 | GBX302.71 Million | +25.68% |
| 2019-08-31 | GBX240.86 Million | -8.49% |
| 2018-08-31 | GBX263.22 Million | -3.35% |
| 2017-08-31 | GBX272.34 Million | +17.83% |
| 2016-08-31 | GBX231.12 Million | -11.68% |
| 2015-08-31 | GBX261.68 Million | +15.99% |
| 2014-08-31 | GBX225.61 Million | +30.49% |
| 2013-08-31 | GBX172.90 Million | +33.90% |
| 2012-08-31 | GBX129.12 Million | +27.44% |
| 2011-08-31 | GBX101.32 Million | +6.57% |
| 2010-08-31 | GBX95.07 Million | -3.70% |
| 2009-08-31 | GBX98.72 Million | -13.92% |
| 2008-08-31 | GBX114.69 Million | +10.16% |
| 2007-08-31 | GBX104.11 Million | +55.11% |
| 2006-08-31 | GBX67.12 Million | +14.27% |
| 2005-08-31 | GBX58.73 Million | +5.77% |
| 2004-08-31 | GBX55.53 Million | +2.19% |
| 2003-08-31 | GBX54.34 Million | +11.96% |
| 2002-08-31 | GBX48.54 Million | -51.74% |
| 2001-08-31 | GBX100.58 Million | -72.53% |
| 2000-08-31 | GBX366.17 Million | -- |